Herein, the current results showed that CD8+ T cells from the bloods of normal controls or from the bloods or the liver of HCC patients were able to kill HepG2 cells in an indirect way, which seemed controversial from previous reports. This evidence concerns the gene CD8A and hepatocellular carcinoma.